KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bionano Genomics (BNGO) Net Income towards Common Stockholders (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Net Income towards Common Stockholders for 9 consecutive years, with -$7.9 million as the latest value for Q4 2025.

  • Quarterly Net Income towards Common Stockholders rose 61.42% to -$7.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$26.4 million through Dec 2025, up 76.53% year-over-year, with the annual reading at -$26.4 million for FY2025, 76.53% up from the prior year.
  • Net Income towards Common Stockholders hit -$7.9 million in Q4 2025 for Bionano Genomics, up from -$8.5 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$3.1 million in Q1 2025 to a low of -$112.6 million in Q3 2023.
  • Historically, Net Income towards Common Stockholders has averaged -$28.8 million across 5 years, with a median of -$26.5 million in 2021.
  • Biggest five-year swings in Net Income towards Common Stockholders: tumbled 253.88% in 2023 and later skyrocketed 90.13% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$22.9 million in 2021, then plummeted by 68.53% to -$38.7 million in 2022, then fell by 13.48% to -$43.9 million in 2023, then skyrocketed by 53.15% to -$20.6 million in 2024, then soared by 61.42% to -$7.9 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for BNGO at -$7.9 million in Q4 2025, -$8.5 million in Q3 2025, and -$6.9 million in Q2 2025.